PDCD1 and neoplasm: Overexpression of METTL16 has been shown to significantly reduce the proportion of PD-1-positive cells in activated T cells, suggesting that METTL16's regulatory activity may reduce immune evasion and enhance the immune system's ability to recognize and attack tumor cells.51